88 related articles for article (PubMed ID: 12461279)
21. Manganese-DPDP as a hepatobiliary contrast agent in the magnetic resonance imaging of liver tumors. Results of clinical phase II trials in Germany including 141 patients.
Rummeny E; Ehrenheim C; Gehl HB; Hamm B; Laniado M; Lodemann KP; Schmiedel E; Steudel A; Vogl TG
Invest Radiol; 1991 Nov; 26 Suppl 1():S142-5; discussion S150-5. PubMed ID: 1808111
[No Abstract] [Full Text] [Related]
22. Double gallbladder diagnosed on contrast-enhanced MR cholangiography with mangafodipir trisodium.
Milot L; Partensky C; Scoazec JY; Valette PJ; Pilleul F
AJR Am J Roentgenol; 2005 Mar; 184(3 Suppl):S88-90. PubMed ID: 15728034
[No Abstract] [Full Text] [Related]
23. Contrast-enhanced MR imaging of the pancreas.
Kettritz U; Semelka RC
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):87-100. PubMed ID: 8673719
[TBL] [Abstract][Full Text] [Related]
24. Unexpected MR-T1 enhancement of endocrine liver metastases with mangafodipir.
Mathieu D; Coffin C; Kobeiter H; Caseiro-Alves F; Mahfouz A; Rahmouni A; Diche T
J Magn Reson Imaging; 1999 Aug; 10(2):193-5. PubMed ID: 10441024
[TBL] [Abstract][Full Text] [Related]
25. Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images.
Karabacakoğlu A; Adigüzel Y; Karaköse S; Kayaçetin E; Haykir R
Turk J Gastroenterol; 2006 Sep; 17(3):164-71. PubMed ID: 16941248
[TBL] [Abstract][Full Text] [Related]
26. [Magnetic resonance tomography of the hepatobiliary system: indications, limitations and outlook].
Vogl TJ; Hammerstingl R; Schnell B; Eibl-Eibesfeldt B; Peqios W; Lissner J
Bildgebung; 1992 Dec; 59(4):195-9. PubMed ID: 1292771
[TBL] [Abstract][Full Text] [Related]
27. Mn-DPDP in MR imaging of pancreatic adenocarcinoma: initial clinical experience.
Gehl HB; Urhahn R; Bohndorf K; Klever P; Hauptmann S; Lodemann KP; Matern S; Schumpelick V; Günther RW
Radiology; 1993 Mar; 186(3):795-8. PubMed ID: 8430190
[TBL] [Abstract][Full Text] [Related]
28. On the AJR viewbox. Intrapancreatic accessory spleen: diagnosis with RES-specific contrast-enhanced MRI.
Boraschi P; Donati F; Volpi A; Campori G
AJR Am J Roentgenol; 2005 May; 184(5):1712-3. PubMed ID: 15855152
[No Abstract] [Full Text] [Related]
29. A segmental hyperintensity area in the liver shown by delayed MR images with Mn-DPDP.
Suto Y; Weinreb JC; Rofski NM
J Comput Assist Tomogr; 1996; 20(4):647-9. PubMed ID: 8708073
[TBL] [Abstract][Full Text] [Related]
30. Experimental liver cancers: Mn-DPDP-enhanced rims in MR-microangiographic-histologic correlation study.
Ni Y; Marchal G; Yu J; Rummeny E; Zhang X; Lodemann KP; Baert AL
Radiology; 1993 Jul; 188(1):45-51. PubMed ID: 8390071
[TBL] [Abstract][Full Text] [Related]
31. Hepatobiliary contrast material: a magic bullet for sensitivity and specificity?
Mitchell DG
Radiology; 1993 Jul; 188(1):21-2. PubMed ID: 8511300
[No Abstract] [Full Text] [Related]
32. Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases.
Mühler A; Clément O; Vexler V; Berthezène Y; Rosenau W; Brasch RC
Radiology; 1992 Jul; 184(1):207-13. PubMed ID: 1609081
[TBL] [Abstract][Full Text] [Related]
33. Diffuse desmoplastic breast carcinoma metastases to the liver simulating cirrhosis at MR imaging: report of two cases.
Nascimento AB; Mitchell DG; Rubin R; Weaver E
Radiology; 2001 Oct; 221(1):117-21. PubMed ID: 11568328
[TBL] [Abstract][Full Text] [Related]
34. Detection of liver metastases from gastrointestinal cancer: comparision of high resolution MnDPDP enhanced MRI and FDG-PET.
Kalva SP; Sahani DV; Ryan D; Fischman AJ; Hahn PF; Mueller P; Saini S
Acad Radiol; 2005 May; 12 Suppl 1():S17-20. PubMed ID: 16106540
[No Abstract] [Full Text] [Related]
35. Clinical hepatic imaging with paramagnetic positive enhancers.
Bernardino ME
Magn Reson Med; 1991 Dec; 22(2):334-8; discussion 343-6. PubMed ID: 1812367
[No Abstract] [Full Text] [Related]
36. Mn-DPDP-enhanced 24-h delayed-scan MRI of hepatocellular carcinoma is correlated with histology.
Wang DB; Zhou KR; Zeng MS; Chen KM; Wang YX
Eur Radiol; 2004 Apr; 14(4):743-5. PubMed ID: 12802614
[No Abstract] [Full Text] [Related]
37. Pseudocirrhosis in metastatic breast cancer.
Hidalgo-Blanco A; Aguirresarobe-Gil de San Vicente M; Aresti S; de Miguel E; Cabriada-Nuno JL
Gastroenterol Hepatol; 2018 Feb; 41(2):111-113. PubMed ID: 28187872
[No Abstract] [Full Text] [Related]
38. Parasitic Infestation Mimicking Hepatic Metastasis with Four Different Imaging Modalities in a Patient with Breast Carcinoma.
Gunes BY; Özvar FH; Demirci E; Özkurt H; Baytekin HF; Kabuli H
Breast J; 2017 Jul; 23(4):468-470. PubMed ID: 28117529
[No Abstract] [Full Text] [Related]
39. Subacute liver failure by pseudocirrhotic metastatic breast cancer infiltration.
Jüngst C; Krämer J; Schneider G; Lammert F; Zimmer V
Ann Hepatol; 2013; 12(5):834-6. PubMed ID: 24018505
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of pancreas and diagnosis of pancreatitis using manganese dipyridoxyl diphosphate.
Baba Y; Lerch MM; Tanimoto A; Kreft BP; Saluja AK; Zhao L; Chen J; Steer ML; Stark DD
Invest Radiol; 1994 Jun; 29 Suppl 2():S300-1. PubMed ID: 7928263
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
